...

522-054

CAS
1243273-19-9
Molecular wt
375.4
Compound class
Triazolopyridazine ([1,2,4]triazolo[4,3-b]pyridazine) derivative
Not in stock yet
  1. In synthesis
  2. In transit
  3. Received
  4. In testing
The supplier has shipped it and it is on its way to us. This is a new product rather than one that sold out, so there is no back-in-stock date to give you yet.

522-054

522-054 is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms and Conditions prior to ordering.

What is the difference between these?
Dry-Fill Capsule
Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Liquid Dropper
The compound already in solution, in a dropper bottle. The label gives the amount per millilitre, the bottle volume and the total.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

SSL secure checkout

256-bit encryption

3rd party verified

HPLC and mass spectrometry

Description

522-054 Research Standard

522-054, chemically identified as 3-(2,5-difluorophenyl)-6-(1-ethyl-1H-indol-5-yl)-1,2,4-triazolo[4,3-b]pyridazine, is a triazolopyridazine-class research compound described in the scientific literature as a dual allosteric modulator of two Cys-loop ligand-gated ion channels. It was designed to enhance α7 neuronal nicotinic acetylcholine receptors (α7 nAChRs) and inhibit α5 subunit-containing GABAA receptors (α5 GABAARs) within a single molecule. In controlled laboratory environments, 522-054 allows researchers to observe how simultaneous modulation of two related receptor families shapes hippocampal network activity, synaptic plasticity, and measures of cognition in cellular and animal models.

Technical Specifications

Property Specification
Product Name 522-054
Chemical Name 3-(2,5-Difluorophenyl)-6-(1-ethyl-1H-indol-5-yl)-1,2,4-triazolo[4,3-b]pyridazine
Common Synonyms 522054, Compound 522-054
CAS Number 1243273-19-9
Chemical Formula C21H15F2N5
Molecular Weight 375.4 g/mol
Chemical Class Triazolopyridazine ([1,2,4]triazolo[4,3-b]pyridazine) derivative
Physical Appearance White to off-white powder
Assay Purity Refer to the batch-specific Certificate of Analysis (COA) supplied for the lot received
Solution Base PEG400

Mechanism of Action & Research Context

522-054 is investigated for its capacity to act on two related ligand-gated ion channels at once, rather than as a direct agonist at either.

  • Dual Allosteric Design: Published characterization describes the molecule as designed to simultaneously inhibit α5 GABAA receptors and enhance α7 nAChRs. Both receptors belong to the Cys-loop family and both regulate hippocampal circuits that support declarative memory, which makes a single dual-acting ligand a useful tool for testing whether the two mechanisms combine.

  • Hippocampal Synaptic Plasticity: In rat hippocampal slices, the compound reproduces the long-term potentiation of mossy fiber stimulation-induced excitatory postsynaptic currents in CA1 pyramidal neurons that is otherwise produced by applying two separate modulators together. Selective antagonists at either receptor block the sustained potentiation, which is the experiment that ties the effect to both targets rather than to one.

  • Behavioral Correlates: Reported in vivo work describes enhanced performance in the radial arm maze and facilitation of attentional states in the five-choice serial reaction time task, with the same antagonist sensitivity observed in the slice experiments.

  • Injury Models: A separate published study applied the compound during the chronic recovery period following experimental traumatic brain injury in rats, reporting reduced deficits in basal synaptic transmission and recovery of injury-impaired long-term potentiation in hippocampal slices, alongside improvements in fear memory and water maze measures without a measurable effect on cortical or hippocampal atrophy.

Research Applications

522-054 is a specialized reagent for ligand-gated ion channel and hippocampal circuit research.

Primary fields of in vitro laboratory investigation include:

  • Cys-Loop Receptor Pharmacology: Characterizing positive and negative allosteric modulation at α7 nAChRs and α5 GABAARs in recombinant expression systems.

  • Electrophysiology and Plasticity Assays: Measuring excitatory postsynaptic currents and long-term potentiation at hippocampal synapses under single-target and dual-target modulation.

  • Antagonist-Block Study Design: Using selective α7 nAChR and α5 GABAAR antagonists to separate the contribution of each target to an observed network effect.

  • Structure–Activity Relationship (SAR) Studies: Comparing substituted 1,2,4-triazolo[4,3-b]pyridazine analogs to map how aryl and indolyl substitution shape activity at each receptor.

  • Analytical Reference Work: Serving as a reference material for chromatographic and mass-spectrometric identification and method development.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed. Liquid formats: do not refrigerate or freeze. Cold storage may cause the solution to cloud or precipitate. If this occurs, return to room temperature and mix until clear.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this research material solely to qualified institutions and professional investigators for authorized laboratory research.

Compound Class Triazolopyridazine ([1,2,4]triazolo[4,3-b]pyridazine) derivative
CAS Number 1243273-19-9
Other Names 522054, Compound 522-054
IUPAC Name 3-(2,5-Difluorophenyl)-6-(1-ethyl-1H-indol-5-yl)-1,2,4-triazolo[4,3-b]pyridazine
Molecular Formula C21H15F2N5
Molecular Weight 375.4
Capsule Concentration 250mcg x 60ct
Liquid Concentration And Solution 500mcg/ml PEG400